Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful survival benefits ...

Eflornithine plus lomustine improved survival in recurrent grade 3 IDH-mutant astrocytoma compared to lomustine alone, with significant gains in progression-free and overall survival. The STELLAR ...

– OS and PFS Study endpoints met in large subgroup of patients with recurrent astrocytoma, IDH mutant grade 3 as defined by the 2021 WHO CNS Tumor Classification in Orbus Therapeutics’ Phase 3 STELLAR ...

This type of brain tumor can range from slow-growing to highly aggressive forms. Learn how astrocytomas are diagnosed and treated and what factors influence a person’s outlook and recovery.

Astrocytoma is the most common type of glioma tumour affecting the brain and spinal cord. Originating from star-shaped brain cells called astrocytes, astrocytomas account for nearly 50% of all primary ...